Key Details
Price
$39.98Annual ROE
-26.62%Beta
1.13Events Calendar
Next earnings date:
May 7, 2025Recent quarterly earnings:
Feb 26, 2025Recent annual earnings:
Feb 26, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 27, 25 Needham
BuyFeb 27, 25 HC Wainwright & Co.
BuyFeb 27, 25 Goldman Sachs
BuyJan 17, 25 Goldman Sachs
BuyJan 10, 25 HC Wainwright & Co.
BuyNov 14, 24 HC Wainwright & Co.
BuyNov 8, 24 HC Wainwright & Co.
BuyOct 15, 24 HC Wainwright & Co.
BuySep 23, 24 Cantor Fitzgerald
OverweightSep 12, 24 Needham
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
MoonLake Immunotherapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for MoonLake Immunotherapeutics?
- Does MoonLake Immunotherapeutics pay dividends?
- What sector is MoonLake Immunotherapeutics in?
- What industry is MoonLake Immunotherapeutics in?
- What country is MoonLake Immunotherapeutics based in?
- When did MoonLake Immunotherapeutics go public?
- Is MoonLake Immunotherapeutics in the S&P 500?
- Is MoonLake Immunotherapeutics in the NASDAQ 100?
- Is MoonLake Immunotherapeutics in the Dow Jones?
- When was MoonLake Immunotherapeutics's last earnings report?
- When does MoonLake Immunotherapeutics report earnings?
- Should I buy MoonLake Immunotherapeutics stock now?
What is the ticker symbol for MoonLake Immunotherapeutics?
The ticker symbol for MoonLake Immunotherapeutics is NASDAQ:MLTX
Does MoonLake Immunotherapeutics pay dividends?
No, MoonLake Immunotherapeutics does not pay dividends
What sector is MoonLake Immunotherapeutics in?
MoonLake Immunotherapeutics is in the Healthcare sector
What industry is MoonLake Immunotherapeutics in?
MoonLake Immunotherapeutics is in the Biotechnology industry
What country is MoonLake Immunotherapeutics based in?
MoonLake Immunotherapeutics is headquartered in Switzerland
When did MoonLake Immunotherapeutics go public?
MoonLake Immunotherapeutics's initial public offering (IPO) was on October 20, 2020
Is MoonLake Immunotherapeutics in the S&P 500?
No, MoonLake Immunotherapeutics is not included in the S&P 500 index
Is MoonLake Immunotherapeutics in the NASDAQ 100?
No, MoonLake Immunotherapeutics is not included in the NASDAQ 100 index
Is MoonLake Immunotherapeutics in the Dow Jones?
No, MoonLake Immunotherapeutics is not included in the Dow Jones index
When was MoonLake Immunotherapeutics's last earnings report?
MoonLake Immunotherapeutics's most recent earnings report was on Feb 26, 2025
When does MoonLake Immunotherapeutics report earnings?
The next expected earnings date for MoonLake Immunotherapeutics is May 7, 2025
Should I buy MoonLake Immunotherapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions